Bullish on BNB? Windtree Therapeutics unveils $520m funding plan

21 hours ago 1



Nasdaq-listed Windtree Therapeutics unveils new funding plans to generate $520 million. Most of the funds will be used to accelerate the firm’s BNB treasury strategy.

Summary

  • Windtree Therapeutics has signed two funding agreements that will generate $520 million to buy more BNB.
  • WINT stocks received a slight boost from announcing a BNB funding strategy.

According to a recent press release, the Nasdaq-listed biotechnology company announced that it has signed an equity line of credit agreement or ELOC that could generate the company up to $500 million in funds. The funding will be used to “bolster its BNB cryptocurrency treasury strategy.”

In addition, the company has also taken part in a $20 million stock purchase deal with Build and Build Corp. When combined with the ELOC agreement, the two fundraising initiatives could generate up to $520 million for Windtree Therapeutics.

Windtree Therapeutics plans to use 99% of the proceeds received from the ELOC agreement and the stock purchase deal with Build and Build Corp to buy more Binance Coin (BNB) for its treasury.

However, the company does note that it will not use funds from the ELOC agreement to buy more Binance Coin if shareholders do not approve of increasing the number of authorized shares on the market.

 crypto.news Price chart for BNB in the past few hours of trading, July 25, 2025, Source: crypto.news

If the company’s stockholders approve of the plan, Windtree Therapeutics could purchase as much as 676,371 BNB using 99% of the $520 million generated from the Build and Build Corp deal and the ELOC agreement. At press time, Binance Coin has dipped slightly by 0.15%. Each token is currently valued at $761.12.

Earlier this month, as previously reported by crypto.news, the company also announced plans to buy $60 million worth of Binance Coins after signing a securities purchase agreement with Build and Build Corp among other firms contributing to the fundraising effort.

Windtree Therapeutics’ stock gains a boost after BNB funding plan

According to data from Google Finance, the Windtree Therapeutics stock has soared by 4.87% following the firm’s declaration that it would use 99% of the $520 million funds to buy more Binance Coin.

As of July 25, the WINT stock is currently trading hands on the market at a price of $1,02. Throughout the first half of 2025, the company’s stock has surged by 537.5% in the past six months and 175.6% in the past month. This boost may be due to the company adopting a BNB treasury strategy in mid-July 2025.

CEO of Windtree, Jed Latkin said that the firm plans to incorporate new facilities of funding to further accelerate its business strategy to build on its crypto reserves.

“Pending stockholder approval, the opportunity to secure additional funds for purchasing more BNB cryptocurrency is essential to our strategy,” said Latkin in his statement.

Read Entire Article